검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-8 · 마지막 7월 21일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | pneumococcal conjugate vaccine (pneumococcal conjugate vaccine) Pfizer·Rheumatoid Arthritis ORR 89.87% |
|---|---|
Overview Program | pneumococcal conjugate vaccine |
Overview Company | Pfizer |
Overview Modality | ADC |
Overview Target | Rheumatoid Arthritis |
Overview Indication | Rheumatoid Arthritis |
Overview Phase | PRECLINICAL |
Overview Status | ACTIVE |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse, In vitro |
PK/PD Experiment | PD |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse, In vitro |
Toxicology Major finding | Comparative Efficacy and Safety of 15-Valent and 13-Valent Pneumococcal Conjugate Vaccines Alone and in Combination with the 23-Valent Polysaccharide Vaccine: A Systematic Review and Meta-analysis.. In addition to the 23-valent pneumococcal polysaccharide vaccine (PPSV23), the 13-valent and 15-valent pneumococcal conjugate vaccines (PCV13 and PCV15, respectively) are currently utilized as optional… |
Toxicology CRS | Reported |
Clinical Primary efficacy | ORR 89.87% |
Clinical ORR | 89.87% |
Clinical Result source | ClinicalTrials.gov NCT01480258 |
Clinical Data Tier / Score | A · 47 |
Clinical Program phase | PRECLINICAL |
Clinical Clinical sync | 2026년 7월 18일 (8일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-8 · 마지막 7월 21일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | pneumococcal conjugate vaccine (pneumococcal conjugate vaccine) Pfizer·Rheumatoid Arthritis ORR 89.87% |
|---|---|
Overview Program | pneumococcal conjugate vaccine |
Overview Company | Pfizer |
Overview Modality | ADC |
Overview Target | Rheumatoid Arthritis |
Overview Indication | Rheumatoid Arthritis |
Overview Phase | PRECLINICAL |
Overview Status | ACTIVE |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse, In vitro |
PK/PD Experiment | PD |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse, In vitro |
Toxicology Major finding | Comparative Efficacy and Safety of 15-Valent and 13-Valent Pneumococcal Conjugate Vaccines Alone and in Combination with the 23-Valent Polysaccharide Vaccine: A Systematic Review and Meta-analysis.. In addition to the 23-valent pneumococcal polysaccharide vaccine (PPSV23), the 13-valent and 15-valent pneumococcal conjugate vaccines (PCV13 and PCV15, respectively) are currently utilized as optional… |
Toxicology CRS | Reported |
Clinical Primary efficacy | ORR 89.87% |
Clinical ORR | 89.87% |
Clinical Result source | ClinicalTrials.gov NCT01480258 |
Clinical Data Tier / Score | A · 47 |
Clinical Program phase | PRECLINICAL |
Clinical Clinical sync | 2026년 7월 18일 (8일 전) |
추천 비교
추천 비교